79158397 - VIFOR PHARMA

Information

• Trademark
• 79158397

• Source

• Serial Number

  79158397

• Registration Number

  4948439

• International Classifications

  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 39 - Transport
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  September 18, 2014
  9 years ago

• Registration Date

  May 03, 2016
  8 years ago

• Transaction Date

  July 18, 2023
  a year ago

• Status Date

  November 18, 2022
  a year ago

• Published for Opposition Date

  February 16, 2016
  8 years ago

• Location Date

  May 03, 2016
  8 years ago

• Status Code

  709

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  JUN, WON KYUNG WENDY

• Attorney Docket Number

  04474.000100

  Law Office Assigned Location Code

  L30

• Owners

  • Galenica AG

Case File Statements

• GS0411: Business training services as relating to pharmaceutical and sanitary products
• DM0000: The mark consists of the wording "VIFOR PHARMA". To the left of the wording is a design element of three horizontal straight lines stacked on top of each other.
• GS0391: Transport, storage, delivery, and packaging of goods, namely, medicines, pharmaceutical and sanitary preparations
• GS0051: Pharmaceutical preparations for the treatment and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, iron deficiency anemia, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes and related diseases, and migraines and other forms of headache; Pharmaceutical products for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, such as acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, and toxin damage to the kidney; analgesics; antiviral; anti-infectives; anti-inflammatories; antibiotics; antidepressants; anti-cancer preparations; pharmaceutical preparations for use in organ and tissue transplantation; preparations for the treatment of immunologic diseases; pharmaceutical preparations for dialysis and conditions associated with dialysis; preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for treatment of water and electrolyte metabolism disorders and disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; preparations used as immune system stimulators; scabicides; anti-malarials; cough treatment preparations, namely, cough suppressants; preparations for treating coughs and colds; expectorants; anti-leukemic agents; dermatologicals; tissue sealants; vasopressors; pharmaceutical preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; preparations for the treatment of gout; preparations for cessation of smoking; preparations of treatment of Parkinson's disease; vaccines; antiemetics; nasal spray preparations; sanitary preparations for medical uses; parapharmaceutical products for use in dermatology; dietetic foods, namely, dietary supplement; preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teeth; dental wax; all-purpose disinfectants
• GS0031: Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifrices
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: Import agency services in the field of medicines and pharmaceutical preparations; retail store services featuring pharmaceutical and sanitary preparations; import-export agencies in the fields of medicines, pharmaceutical and sanitary preparations
• GS0451: Legal services and legal representation of third parties to the authorities and administration with respect to approval of medicines
• TR0010: The wording "VIFOR" has no meaning in a foreign language.
• D10000: "PHARMA"
• GS0421: Research and development of medicines, pharmaceutical preparations and sanitary care products for others

Case File Event Statements

• 7/18/2023 - a year ago

  42 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 11/18/2022 - a year ago

  41 - CANCELLED SECTION 71 Type: C71T

• 11/30/2021 - 2 years ago

  40 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 9/13/2018 - 6 years ago

  39 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 10/5/2017 - 6 years ago

  38 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD

• 2/17/2017 - 7 years ago

  37 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 8/9/2016 - 8 years ago

  36 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/9/2016 - 8 years ago

  35 - FINAL DISPOSITION PROCESSED Type: FIMP

• 8/3/2016 - 8 years ago

  34 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 5/3/2016 - 8 years ago

  33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/16/2016 - 8 years ago

  32 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/12/2016 - 8 years ago

  31 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 1/27/2016 - 8 years ago

  30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/27/2016 - 8 years ago

  29 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/27/2016 - 8 years ago

  28 - NOTICE OF PUBLICATION Type: NPUB

• 1/13/2016 - 8 years ago

  27 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 1/11/2016 - 8 years ago

  26 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/8/2016 - 8 years ago

  25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/8/2016 - 8 years ago

  24 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/7/2016 - 8 years ago

  23 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 1/7/2016 - 8 years ago

  22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/6/2016 - 8 years ago

  21 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/5/2016 - 8 years ago

  20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/5/2016 - 8 years ago

  19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/5/2016 - 8 years ago

  18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 7/9/2015 - 9 years ago

  17 - FINAL REFUSAL MAILED Type: CNFR

• 7/8/2015 - 9 years ago

  16 - FINAL REFUSAL WRITTEN Type: CNFR

• 6/9/2015 - 9 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/9/2015 - 9 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/1/2015 - 9 years ago

  13 - ASSIGNED TO LIE Type: ALIE

• 5/27/2015 - 9 years ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/23/2015 - 9 years ago

  11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 4/23/2015 - 9 years ago

  10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 2/6/2015 - 9 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/13/2015 - 9 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/13/2015 - 9 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 1/13/2015 - 9 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 1/11/2015 - 9 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 1/10/2015 - 9 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/8/2015 - 9 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/8/2015 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/2/2015 - 9 years ago

  1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC